Svishchenko E P, Kupchinskaia E G, Zanozdra N S, Bezrodnaia L V, Radchenko V V
Klin Med (Mosk). 1992 Nov-Dec;70(11-12):34-7.
Essential hypertension stage II was treated by calcium antagonists, alpha- and beta-adrenoblockers in 362 patients. The drugs were compared for hypotensive efficiency at rest and exercise. A significant hypotensive effect was achieved in 81%, 58%, 44%, 43% and 37% of patients treated with labetalol, nifedipine, nadolol, propranolol, diltiazem, respectively. An increase in verapamil daily dose from 240 to 600 mg led to a rise in efficacy from 27 to 75% without an increase in the number of side effects. The antihypertensive effect of the drugs is shown to persist in long-term treatment as shown by exercise tests and static loads.
362例原发性高血压II期患者接受了钙拮抗剂、α和β肾上腺素能阻滞剂治疗。比较了这些药物在静息和运动时的降压效果。接受拉贝洛尔、硝苯地平、纳多洛尔、普萘洛尔、地尔硫䓬治疗的患者中,分别有81%、58%、44%、43%和37%取得了显著降压效果。维拉帕米日剂量从240毫克增加到600毫克,疗效从27%提高到75%,且副作用数量未增加。运动试验和静态负荷表明,这些药物的降压作用在长期治疗中持续存在。